Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Asset icon - trade crypto, stocks, and gold on Pluang

Buy & Sell Inovio Pharmaceuticals Inc (INO) – Inovio Pharmaceuticals Inc Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

INO trades at $1.36, down 3.55% today, amid mixed signals. The stock shows a bullish technical trend with moving averages supporting upside, but RSI levels suggest overbought conditions. Fundamentally, the company faces severe challenges with negligible revenue of $217,760 in 2024 and a net loss of $107.25 million, resulting in negative profit margins and return metrics. Recent quarterly EPS beats offer some optimism, but persistent cash burn and class-action lawsuits cloud the outlook.
The outlook remains high-risk. Analyst consensus leans bullish with 53% buy ratings, but the stock's viability hinges on successful drug development and commercialization. Key risks include ongoing litigation, cash flow sustainability, and failure to achieve revenue growth. Investors should weigh the speculative potential against substantial financial and legal headwinds.
Read full analysis

Key Stats

  • Market Cap
    $109.33M
  • Sector
    Health
  • 3M Drawdown
    -44.44%
  • Enterprise Value
    $60.19M
  • Dividend Yield
    -
  • Trading Activity
    80% Buy | 20% Sell
  • Typical Hold Time
    39 days
$1.34
52W Low: $1.05
07 Apr 2026
52W High: $2.87
08 Sep 2025

Inovio Pharmaceuticals Inc (INO) is currently valued at a market capitalization of $109.33M, with an enterprise value of $60.19M. Over the past 52 weeks, Inovio Pharmaceuticals Inc has traded between a low of $1.05 and a high of $2.87, highlighting its annual price range. Over the past three months, Inovio Pharmaceuticals Inc has recorded a drawdown of -44.44%, reflecting recent price volatility. On average, investors hold Inovio Pharmaceuticals Inc for approximately 39 days, indicating typical investor behavior on the platform.

About Inovio Pharmaceuticals Inc

Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.


Technical Indicators
|
|
|
Overall Summary
Bearish (14)Neutral (3)Bullish (10)

People also bought


US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions

Key Stats

  • Market Cap
    $109.33M
  • Sector
    Health
  • 3M Drawdown
    -44.44%
  • Enterprise Value
    $60.19M
  • Dividend Yield
    -
  • Trading Activity
    80% Buy | 20% Sell
  • Typical Hold Time
    39 days
$1.34
52W Low: $1.05
07 Apr 2026
52W High: $2.87
08 Sep 2025

Inovio Pharmaceuticals Inc (INO) is currently valued at a market capitalization of $109.33M, with an enterprise value of $60.19M. Over the past 52 weeks, Inovio Pharmaceuticals Inc has traded between a low of $1.05 and a high of $2.87, highlighting its annual price range. Over the past three months, Inovio Pharmaceuticals Inc has recorded a drawdown of -44.44%, reflecting recent price volatility. On average, investors hold Inovio Pharmaceuticals Inc for approximately 39 days, indicating typical investor behavior on the platform.

Let’s invest in this asset by signing up or download!